By selling copycat weight-loss drugs, WeightWatchers has become a copycat business
Briefly

WeightWatchers' shift to selling compounded versions of weight-loss drugs like Ozempic and Wegovy aims to ensure access to effective alternatives amid ongoing shortages and insurance denials.
Under interim CEO Tara Comonte, WeightWatchers plans to become an online pharmacy, responding to a market shift driven by popular weight-loss medications while working to stabilize its revenue.
Read at Fast Company
[
|
]